Puffing on an asthma inhaler cuts three days off the length of time people are taking to recover from COVID, Report informs, referring to the Telegraph.

In a parliamentary answer, the health minister Jo Churchill disclosed that a government study had found ‘inhaled budesonide reduced the time to self-reported recovery by a median of three days.’

Inhaled budesonide had been trialed among non-hospitalized COVID patients who are 65 and over or 50 and over with an underlying health condition earlier this year, she said.

Inhaled budesonide is a medicine used for asthma and chronic obstructive pulmonary disease and is taken using a brown or beige inhaler to stave off shortness of breath. The minister added that the findings were currently only based on interim results, and “the full analysis is currently underway to understand the full benefit of this treatment.”